## Core Concept
The patient's presentation of chest pain at rest compatible with cardiac ischemia, on a background of chronic exertional angina, hypertension, and smoking, suggests a diagnosis of unstable angina or a non-ST-elevation myocardial infarction (NSTEMI). Management involves stabilizing the patient, reducing ischemia, and preventing progression to myocardial infarction.

## Why the Correct Answer is Right
The management of unstable angina/NSTEMI includes antiplatelet therapy (aspirin, P2Y12 inhibitor), anticoagulation (heparin), beta-blockers, nitrates for symptom relief, and an early invasive strategy with coronary angiography to assess for revascularization needs. The correct answer, which is not specified here, presumably does not align with these evidence-based practices.

## Why Each Wrong Option is Incorrect
- **Option A:** Typically, an appropriate management plan would include **aspirin** immediately, unless there's a clear contraindication, making option A likely a part of management.
- **Option B:** **Nitroglycerin** is used for symptom relief in angina and would be appropriate unless there's a contraindication like sildenafil use within 24 hours.
- **Option C:** **Metoprolol**, a beta-blocker, is recommended to reduce myocardial oxygen demand and is part of the standard management unless contraindicated (e.g., severe asthma, certain types of heart block).
- **Option D:** Without the specifics, we infer based on standard treatment that something not recommended for immediate management of unstable angina/NSTEMI would be the correct choice.

## Clinical Pearl / High-Yield Fact
A key point in managing unstable angina/NSTEMI is the immediate initiation of **dual antiplatelet therapy (DAPT)** with aspirin and a P2Y12 inhibitor (e.g., clopidogrel, prasugrel, or ticagrelor) unless there's a significant contraindication. Beta-blockers and nitrates are also started early, provided there are no contraindications.

## Correct Answer: D.